Indaptus Therapeutics, Inc.
Pharmaceutical company · New York, United States · Nasdaq: INDP
Indaptus Therapeutics, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker INDP. It has reported private securities offerings to the US SEC, most recently $2.3 million sold in a notice filed in 2025.
Indaptus Therapeutics at a glance
What does Indaptus Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $2.3 million sold (2025).
Frequently asked questions about Indaptus Therapeutics
Where is Indaptus Therapeutics headquartered?
Indaptus Therapeutics, Inc. is headquartered in New York, United States.
What does Indaptus Therapeutics do?
Indaptus Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Indaptus Therapeutics a public company?
Yes. Indaptus Therapeutics, Inc. trades on Nasdaq under the ticker INDP.
When was Indaptus Therapeutics founded?
The earliest incorporation on record for Indaptus Therapeutics, Inc. is in 2021, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.